Evidence map›Paper›PMID 31114589›Full record

ArticleFrontiers in immunology2019

High-Content Screening Identifies Vanilloids as a Novel Class of Inhibitors of NET Formation.

Elvira Sondo, Roberta Bertelli, Emanuela Pesce, Gian Marco Ghiggeri, Nicoletta Pedemonte

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Neutrophil Extracellular Traps (NETs) and Vasculitis.International journal of medical sciences · 2021
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Emerging role of NET inhibitors in cardiovascular diseases.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elvira SondoUOC Genetica Medica, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Roberta BertelliUOC Nefrologia, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Emanuela PesceUOC Genetica Medica, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Gian Marco GhiggeriUOC Nefrologia, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Nicoletta PedemonteUOC Genetica Medica, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Istituto Giannina Gaslini · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils migrate to sites of infection where they phagocytose, degranulate, and/or, in the presence of appropriate stimuli, release decondensed chromatin strands (called neutrophil extracellular traps, NETs) for trapping and possibly killing microorganisms. NET formation is characterized by marked morphological cell changes, in particular within the nucleus. Lytic NET formation can be observed in neutrophils undergoing cell death, which is referred to as NETosis. Dysregulation of NET production and/or degradation can exert pathogenic effects, contributing to the pathogenesis of various diseases, including cystic fibrosis, autoimmune diseases and inflammatory conditions. By employing a phenotypic assay based on high-content imaging and analysis, we screened a library of biologically active compounds and identified vanilloids as a novel class of chemical compounds able to hinder NETosis induction and NET release. Vanilloids also markedly decrease cytosolic ROS production. The identification of novel vanilloid NET inhibitors, able to stop excessive or aberrant NET production might offer new therapeutic options for those disorders displaying NET overproduction.

Indexed as

HydroxybenzoatesDrug Evaluation, PreclinicalExtracellular TrapsHumansNeutrophilsHydroxybenzoateshigh-content screeninginhibitorsNETosisNETsneutrophilvanilloids

Identifiers

PMID31114589
PMCPMC6503056
OpenAlexW2943053424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.